remifentanil has been researched along with Ischemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, X; Pan, Z; Su, D; Tian, J; Wang, X; Yang, Z; Zheng, B | 1 |
Aktas, S; Atalay, YO; Kucukodaci, Z; Ozakpinar, OB; Sahin, S | 1 |
Chen, YL; Chen, ZC; Lv, Y; Shen, X; Zhao, G | 1 |
3 other study(ies) available for remifentanil and Ischemia
Article | Year |
---|---|
Remifentanil Ameliorates Liver Ischemia-Reperfusion Injury Through Inhibition of Interleukin-18 Signaling.
Topics: Analgesics, Opioid; Animals; Gene Expression Regulation; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Interferon-gamma; Interleukin-18; Ischemia; Liver; Male; Naloxone; Neutrophils; Peroxidase; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; Signal Transduction; Transaminases | 2015 |
Remifentanil protects uterus against ischemia-reperfusion injury in rats.
Topics: Analgesics, Opioid; Animals; Antioxidants; Catalase; Female; Ischemia; Malondialdehyde; Piperidines; Random Allocation; Rats, Wistar; Remifentanil; Reperfusion Injury; Reproducibility of Results; Superoxide Dismutase; Time Factors; Uterus | 2015 |
[Protective effect of remifentanil preconditioning against hepatic ischemia-reperfusion injury in rats: role of p38 mitogen-activated protein kinases].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Imidazoles; Interleukin-1beta; Ischemia; Ischemic Preconditioning; Liver; Male; MAP Kinase Signaling System; p38 Mitogen-Activated Protein Kinases; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Remifentanil; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2011 |